Literature DB >> 16807266

Phosphodiesterase 4 inhibition of beta2-integrin adhesion caused by leukotriene B4 and TNF-alpha in human neutrophils.

A Y Meliton1, N M Muñoz, A Lambertino, E Boetticher, J Learoyd, X Zhu, A R Leff.   

Abstract

Phosphodiesterase (PDE)4 inhibition attenuates neutrophilic inflammation in chronic obstructive pulmonary disease. The objective of the present study was to examine the efficacy and mechanism by which PDE4 inhibition blocks adhesion of beta(2)-integrin to an endothelial counterligand. Neutrophils (polymorphonuclear leukocytes (PMNs)) were isolated from humans receiving no medication. Adhesion was analysed by myeloperoxidase activity. The effects of cilomilast+/-salmeterol on the following were determined: 1) surface CD11b expression; 2) adhesion; 3) intracellular cyclic adenosine monophosphate (cAMP) concentration; and 4) extracellular signal-regulated kinase (ERK)-1/2-mediated group IVA-phospholipase A(2) (gIVA-PLA(2)) phosphorylation caused by leukotriene (LT)B(4) or tumour necrosis factor (TNF)-alpha activation. Either cilomilast or rolipram+/-salmeterol caused concentration-related blockade of LTB(4)-induced adhesion to counterligand, but had no effect on TNF-alpha-activated PMNs. A comparable increase in intracellular cAMP concentration for PMNs activated with LTB(4) and TNF-alpha was caused by 1 muM cilomilast and 0.1 microM salmeterol. Upregulation of surface CD11b expression and ERK-1/2 phosphorylation were blocked by cilomilast or rolipram+/-salmeterol for PMNs activated by LTB(4), but not for cells stimulated by TNF-alpha. Cilomilast+/-salmeterol also blocked gIVA-PLA(2) phosphorylation caused by LTB(4) but not TNF-alpha. In conclusion, the current study demonstrates that both leukotriene B(4) and tumour necrosis factor-alpha upregulate cyclic adenosine monophosphate. However, cyclic adenosine monophosphate does not block beta(2)-integrin adhesion caused by tumour necrosis factor-alpha. It was concluded that tumour necrosis factor-alpha prevents inhibition of extracellular signal-regulated kinase-1/2-mediated group IVA-phospholipase A(2) activation, which is essential for beta(2)-integrin adhesion in polymorphonuclear leukocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807266     DOI: 10.1183/09031936.06.00028406

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Lung proteomic biomarkers associated with chronic obstructive pulmonary disease.

Authors:  Yu-Hang Zhang; Michael R Hoopmann; Peter J Castaldi; Kirsten A Simonsen; Mukul K Midha; Michael H Cho; Gerard J Criner; Raphael Bueno; Jiangyuan Liu; Robert L Moritz; Edwin K Silverman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-20       Impact factor: 5.464

2.  Hematopoietic Pyk2 regulates migration of differentiated HL-60 cells.

Authors:  Lin Wang; Jonathan Learoyd; Yingli Duan; Alan R Leff; Xiangdong Zhu
Journal:  J Inflamm (Lond)       Date:  2010-05-27       Impact factor: 4.981

3.  Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice.

Authors:  Nilda M Muñoz; Angelo Y Meliton; Lucille N Meliton; Steven M Dudek; Alan R Leff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

4.  Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability.

Authors:  M-J Sanz; J Cortijo; M A Taha; M Cerdá-Nicolás; E Schatton; B Burgbacher; J Klar; H Tenor; C Schudt; A C Issekutz; A Hatzelmann; E J Morcillo
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

Review 5.  Long non-coding RNAs in ischemic stroke.

Authors:  Mei-Hua Bao; Vivian Szeto; Burton B Yang; Shu-Zhen Zhu; Hong-Shuo Sun; Zhong-Ping Feng
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 6.  The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease.

Authors:  Ewa Pniewska; Rafal Pawliczak
Journal:  Mediators Inflamm       Date:  2013-05-13       Impact factor: 4.711

7.  Cytosolic phospholipase A2 (cPLA2) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages.

Authors:  Subodh K Yadav; Sanjeev K Sharma; Abdullah Farooque; Gaurav Kaushik; Balwinder Kaur; Chander M Pathak; Bilikere S Dwarakanath; Krishan L Khanduja
Journal:  Lipids Health Dis       Date:  2016-08-15       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.